Cancer diagnosis and treatment
Patent Information
- Authority / Receiving Office
- EP · EP
- Patent Type
- Applications
- Current Assignee / Owner
- VESTLANDETS INNOVASJONSSELSKAP AS
- Filing Date
- 2024-07-23
- Publication Date
- 2026-06-03
AI Technical Summary
There is a lack of effective biomarkers for the early diagnosis and prediction of pediatric cancers, which hinders the development of improved treatments and leads to serious health-related issues in cancer survivors.
The method involves determining the presence of autoantibodies against specific pediatric cancer-associated antigens or proteins in biological samples from subjects or their mothers during pregnancy or the peripartum period, using techniques such as indirect immunofluorescence and confocal microscopy.
This approach allows for the early detection and prediction of pediatric cancers, potentially improving survival chances and enabling the development of novel, non-toxic treatments by identifying biomarkers that can be used across various cancer types.
Smart Images

Figure EP2024070894_30012025_PF_FP_ABST